Compounds > 3,4-methylenedioxyamphetamine

3,4-methylenedioxyamphetamine and vanoxerine

3,4-methylenedioxyamphetamine has been researched along with vanoxerine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bush, LG; Gibb, JW; Hanson, GR; Johnson, M; Midgley, L1
Pan, HS; Wang, RY1
Brodkin, J; Nash, JF1
Colado, MI; Elliott, JM; Esteban, B; Green, AR; Mechan, AO; O'Shea, E1

Other Studies

4 other study(ies) available for 3,4-methylenedioxyamphetamine and vanoxerine

ArticleYear
MK-801 blocks the changes in neurotensin concentrations induced by methamphetamine, 3,4-methylenedioxymethamphetamine, cocaine, and GBR 12909.
    Annals of the New York Academy of Sciences, 1992, Volume: 668

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Cocaine; Dizocilpine Maleate; Male; Methamphetamine; Neurotensin; Piperazines; Rats; Rats, Sprague-Dawley

1992
MDMA: further evidence that its action in the medial prefrontal cortex is mediated by the serotonergic system.
    Brain research, 1991, Jan-25, Volume: 539, Issue:2

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Cerebral Cortex; Electrophysiology; Fluoxetine; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Uptake Inhibitors; Piperazines; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Stereoisomerism; Stereotaxic Techniques

1991
Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors.
    The Journal of pharmacology and experimental therapeutics, 1991, Volume: 259, Issue:2

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Corpus Striatum; Dialysis; Dopamine; Extracellular Space; Fluoxetine; Ketanserin; Male; Mazindol; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Uptake Inhibitors; Piperazines; Rats; Rats, Inbred Strains; Serotonin

1991
The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.
    British journal of pharmacology, 2002, Volume: 135, Issue:1

    Topics: 3,4-Methylenedioxyamphetamine; Acute Disease; Animals; Benzazepines; Body Temperature; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Fever; Hallucinogens; Hippocampus; Male; Methysergide; N-Methyl-3,4-methylenedioxyamphetamine; Neuroprotective Agents; Piperazines; Piperidines; Rats; Rats, Inbred Strains; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Remoxipride; Ritanserin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists

2002